Pure Global AI
NCT05984979Recruiting

The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes

The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and With Type 1 and 2 Diabetes: an Exploratory Study
University of BernClinicalTrials.govother
Verified
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
Standardized meal
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University of Bern
Location
Bern, Switzerland
Timeline & enrollment
Phase
N/A
Start date
Aug 02, 2023
End date
Jun 30, 2024
Enrollment
60 participants
Primary outcome

VOC Patterns over time as gallery plots,VOC Patterns over time as boxplots

Summary

Exhaled volatile organic compounds will be measured during daytime with the goal to
 identifying circadian variability. The study incudes three subgroups: people without
 diabetes, people with type 1 diabetes, and people with type 2 diabetes. A total of 60 people
 will be recruited for the study.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05984979
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05984979 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Bern and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.